Suzuki H - Search Results

1

Impact of selectin gene polymorphisms on rapid progression to end-stage renal disease in patients with IgA nephropathy.

Watanabe Y, Inoue T, Okada H, Kotaki S, Kanno Y, Kikuta T, Suzuki H. Watanabe Y, et al. Among authors: suzuki h. Intern Med. 2006;45(16):947-51. doi: 10.2169/internalmedicine.45.1641. Epub 2006 Sep 15. Intern Med. 2006. PMID: 16974056 Free article.

2

A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.

Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H. Kanno Y, et al. Among authors: suzuki h. Clin Exp Nephrol. 2003 Mar;7(1):48-51. doi: 10.1007/s101570300006. Clin Exp Nephrol. 2003. PMID: 14586743 Clinical Trial.

3

A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy.

Shoda J, Kanno Y, Suzuki H. Shoda J, et al. Among authors: suzuki h. Intern Med. 2006;45(4):193-8. doi: 10.2169/internalmedicine.45.1515. Epub 2006 Mar 15. Intern Med. 2006. PMID: 16543688 Free article. Clinical Trial.

4

Glomerular solidification is associated with nephritis-related clinical parameters in IgA nephropathy.

Inoue T, Luo Y, Seto T, Suzuki H, Okada H. Inoue T, et al. Among authors: suzuki h. Ren Fail. 2019 Nov;41(1):893-898. doi: 10.1080/0886022X.2019.1665545. Ren Fail. 2019. PMID: 31557071 Free PMC article.

5

Intensive blood pressure reduction is beneficial in patients with impaired cardiac function coexisting with chronic renal insufficiency.

Ikeda N, Suzuki H, Moriwaki K, Sugahara S, Kanno Y, Okada H, Nakamoto H. Ikeda N, et al. Among authors: suzuki h. Hypertens Res. 2002 Jan;25(1):41-8. doi: 10.1291/hypres.25.41. Hypertens Res. 2002. PMID: 11924724 Free article.

6

Systemic capillary leak syndrome.

Chihara R, Nakamoto H, Arima H, Moriwaki K, Kanno Y, Sugahara S, Okada H, Suzuki H. Chihara R, et al. Among authors: suzuki h. Intern Med. 2002 Nov;41(11):953-6. doi: 10.2169/internalmedicine.41.953. Intern Med. 2002. PMID: 12487166 Free article.

7

Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor.

Okada H, Watanabe Y, Inoue T, Kobayashi T, Kikuta T, Kanno Y, Ban S, Suzuki H. Okada H, et al. Among authors: suzuki h. Biochem Biophys Res Commun. 2004 Feb 6;314(2):403-8. doi: 10.1016/j.bbrc.2003.12.105. Biochem Biophys Res Commun. 2004. PMID: 14733919

8

Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism.

Suzuki T, Kanno Y, Nakamoto H, Okada H, Sugahara S, Suzuki H. Suzuki T, et al. Among authors: suzuki h. Adv Perit Dial. 2003;19:148-54. Adv Perit Dial. 2003. PMID: 14763052

9

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.

Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Suzuki H, et al. Am J Kidney Dis. 2004 Jun;43(6):1056-64. doi: 10.1053/j.ajkd.2004.01.019. Am J Kidney Dis. 2004. PMID: 15168386 Clinical Trial.

10

Clinical strategy for the treatment of hypertension in non-diabetic and diabetic nephropathy in Japan.

Kanno Y, Okada H, Nakamoto H, Suzuki H. Kanno Y, et al. Among authors: suzuki h. Contrib Nephrol. 2004;143:145-58. doi: 10.1159/000078718. Contrib Nephrol. 2004. PMID: 15248362 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,181 results

Search Page

Filters